Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on the stock and has a $6.00 price target.

Processa Pharmaceuticals (PCSA  Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3904 Views
Comment
Sign in to post a comment